Karo Pharma intends to change listing venue to Nasdaq First North Growth Market during the first half of 2022
/PRNewswire/ -- The board of directors of Karo Pharma Aktiebolag (publ) (the "Company" or "Karo") has resolved to initiate a process to have the Company's...
Source: prnewswire.co.uk